UGA Researchers Develop Promising Vaccine Against Drug-Resistant Candida Auris

University of Georgia Researchers Develop Vaccine Effective Against Drug-Resistant Candida Auris in Mice Researchers at the University of Georgia have developed a vaccine that demonstrates effectiveness against Candida auris, a drug-resistant fungal pathogen, in mice. The study, conducted by scientists at the UGA Center for Vaccines and Immunology, highlights the vaccine’s potential to combat multiple life-threatening fungal infections. The findings were published in the journal *Vaccines*. Candida auris is known for its resistance to antifungal treatments and its ability to cause severe infections, particularly in healthcare settings. The study tested the pan-fungal vaccine on mice and observed its efficacy in targeting this challenging pathogen. Researchers designed the vaccine to address a broad range of fungal infections, making it a significant step forward in combating fungal diseases that pose serious public health risks. Further research will be necessary to determine its safety and effectiveness in humans. Newsflash | Powered by GeneOnline AI Source: GO-AI-ne1 For any suggestion and feedback, please contact us. Date: January 20, 2026